What to Know About GLP-1 Medications and Weight Management Programs
Learn how Eden connects patients to licensed providers to explore GLP-1 medications as part of medical weight management programs.
Wondering who should not take semaglutide? Learn about medical conditions, contraindications, and safety precautions that may impact GLP-1 eligibility.
Semaglutide is a GLP-1 receptor agonist FDA-approved for managing type 2 diabetes and chronic weight issues. While widely used and effective, it’s not appropriate for everyone.If you're wondering who should not take semaglutide, this guide explains medical contraindications, precautions, and why full provider evaluation is essential before starting therapy.
Semaglutide mimics GLP-1, a hormone released in response to eating. It supports:
This makes it effective for glucose control and weight reduction when paired with lifestyle support.
1. Thyroid Cancer or MEN 2 Syndrome
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2)¹.
2. Pregnancy and Breastfeeding
Semaglutide is not recommended in pregnancy or during lactation². It should be discontinued at least 2 months before trying to conceive.
3. History of Pancreatitis
Cases of acute pancreatitis have been reported following semaglutide use³ ⁴. Patients with prior episodes should be evaluated carefully.
4. Severe Kidney or Liver Disease
Caution is advised in patients with moderate to severe renal or hepatic impairment, especially transplant recipients⁵.
5. Known Allergic Reactions
Avoid semaglutide in known allergy to the drug or its components.
Patients may still qualify for semaglutide but require provider supervision if:
Kidney & Liver Function
Cardiovascular Evaluation
Before starting semaglutide, share:
Your provider may suggest:
Eden connects you with:
Who should not take semaglutide? Patients with MTC, pancreatitis, pregnancy, or significant organ disease may need to avoid or delay use. With professional evaluation, semaglutide can be safe and effective for the right candidates.
This content is for informational purposes and is not a substitute for medical advice. Always consult a licensed provider before starting or stopping any medication.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.